Advanced Oncotherapy on track with LIGHT system

Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy (AVO) has reported continued progress in the development of its next-generation proton beam therapy system, LIGHT, despite the challenges of the Covid-19 pandemic. Announcing its results for the six months ended 30 June 2020, CEO Nicolas Serandour said activities had resumed at the Daresbury site and are expected to be in line with…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »